Author:
Balhara Ankit,Kale Sumeet,Singh Saranjit
Publisher
Springer Nature Singapore
Reference85 articles.
1. Jones HM, Gardner IB, Watson KJ (2009) Modelling and PBPK simulation in drug discovery. AAPS J 11(1):155–166. https://doi.org/10.1208/s12248-009-9088-1
2. Shardlow CE, Generaux GT, Patel AH, Tai G, Tran T, Bloomer JC (2013) Impact of physiologically based pharmacokinetic modeling and simulation in drug development. Drug Metab Dispos 41(12):1994–2003. https://doi.org/10.1124/dmd.113.052803
3. Sager JE, Yu J, Ragueneau-Majlessi I, Isoherranen N (2015) Physiologically based pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification. Drug Metab Dispos 43(11):1823–1837. https://doi.org/10.1124/dmd.115.065920
4. Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, Macintyre F et al (1997) The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharmacol Exp 283(1):46–58. PMID: 9336307
5. Fahmi OA, Maurer TS, Kish M, Cardenas E, Boldt S, Nettleton D (2008) A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro. Drug Metab Dispos 36(8):1698–1708. https://doi.org/10.1124/dmd.107.018663
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献